Medtronic PLC vs Monster Beverage Corp — how do they compare? Medtronic PLC trades at $90.26 (market cap $116.07B), while Monster Beverage Corp trades at $45.47 (market cap $89.20B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays a 3.18% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals.
| MDT | MNST | |
|---|---|---|
Market Cap | $116.07B | $89.20B |
Sector | Health | Consumer Staples |
52-Week High | $105.35 | $49.97 |
52-Week Low | $73.75 | $30.86 |
Enterprise Value | $134.82B | $87.49B |
Dividend Yield | 3.18% | — |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →